Search JRSS
JRSIS Health Care Corporation
OTC Markets OTCID · CIK 1597892
Last close0.01
Daily change+0.00 (0.00%)
10 Years gain-99.76%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
JRSS · STANDARD
SIC 8060 · Services-Hospitals · Fiscal year end 1231
Fundamental
17.0Momentum
n/aAcceleration
n/aConfidence
77.0Annual Revenue10
Quarterly Revenue27
Annual CFO8
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality9.7 / 25
Capital Efficiency0.0 / 20
Balance Sheet6.5 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
No positive signals calculated.
Warnings
Receivables anomaly · MEDIUMAccounts receivable growth is materially above revenue growth.
Heavy share dilution · HIGHDiluted share count increased 10.2156%.
Key Metrics
Revenue Growth TTM-93.64%OK
Revenue CAGR 3Y-54.06%OK
Gross Margin21.47%OK
Operating Margin-23.92%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-173.33%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFO-0.03xOK
Diluted Share Growth 1Y10.22%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 FY Dec 31, 2023 | $3.46M | $483,051.00 | -$188,598.00 | $516,724.00 | $515,240.00 | 13.95% | -5.45% | 14.88% | n/a | 77.25M |
| 2023 FY Dec 31, 2022 | $1.72M | $26,211.00 | -$684,776.00 | -$1.76M | n/a | 1.52% | -39.83% | n/a | -4.92% | 61.33M |
| 2022 FY Dec 31, 2021 | n/a | n/a | -$103,801.00 | $8.23M | n/a | n/a | n/a | n/a | n/a | 18.66M |
| 2021 FY Dec 31, 2021 | $44.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| 2021 FY Dec 31, 2020 | $35.71M | n/a | $5.59M | $10.64M | $2.37M | n/a | 15.67% | 6.64% | 26.54% | 18.27M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1.82M | sum latest 4 fiscal quarters Revenue | OK | 0001213900-24-111011, 0001213900-24-047342 |
| Revenue Growth TTM | -93.64% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001213900-24-111011, 0001213900-24-047342 |
| Revenue CAGR 3Y | -54.06% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001213900-24-036467 |
| Revenue CAGR 5Y | -32.19% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001213900-24-036467 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001213900-24-036467 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001213900-24-111011, 0001213900-24-047342 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 21.47% | Gross Profit / Revenue | OK | 0001213900-24-111011, 0001213900-24-047342 |
| Operating Margin | -23.92% | Operating Income / Revenue | OK | 0001213900-24-111011, 0001213900-24-047342 |
| ROIC | -173.33% | NOPAT / Average Invested Capital | OK | 0001213900-24-111011, 0001213900-24-047342 |
| Net Debt / CFO | -0.03x | Net Debt / CFO | OK | 0001213900-24-111011, 0001213900-24-075805 |
| Current Ratio | 0.78x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.04x | (Cash + Short-term Investments) / Total Debt | OK | 0001213900-24-111011 |
| Revenue per Diluted Share | $0.02 | Revenue / Diluted Shares | OK | 0001213900-24-111011, 0001213900-24-047342 |